Literature DB >> 28343624

Salivary β2-microglobulin positively correlates with ESSPRI in patients with primary Sjögren's syndrome.

Felipe Garza-García1, Guillermo Delgado-García2, Mario Garza-Elizondo3, Luis Ángel Ceceñas-Falcón4, Dionicio Galarza-Delgado5, Janett Riega-Torres3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28343624     DOI： 10.1016/j.rbre.2016.11.001

Source DB:  PubMed          Journal:  Rev Bras Reumatol Engl Ed        ISSN： 2255-5021


× No keyword cloud information.
  3 in total

Review 1.  Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies.

Authors:  Lucía Melguizo-Rodríguez; Victor J Costela-Ruiz; Francisco Javier Manzano-Moreno; Concepción Ruiz; Rebeca Illescas-Montes
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

Review 2.  Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review.

Authors:  Ju-Yang Jung; Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

3.  Beta-2 Microglobulin in Whole Unstimulated Saliva Can Effectively Distinguish Between Sjögren's Syndrome and Non-Autoimmune Sicca Symptoms.

Authors:  Janett Riega-Torres; Guillermo Delgado-García; Julio César Salas-Alanís; Cassandra Skinner-Taylor; Lorena Pérez-Barbosa; Mario Garza-Elizondo; Celia Nohemí Sánchez-Domínguez; Luis Ángel Ceceñas-Falcón; Karim Mohamed-Noriega; Jesús Mohamed-Hamsho; David Vega-Morales
Journal:  Arch Rheumatol       Date:  2017-05-25       Impact factor: 1.472
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.